Lara E Coelho
Overview
Explore the profile of Lara E Coelho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreira A, Moreira R, Coelho L, Jalil E, Bensenor I, Friedman R, et al.
Transgend Health
. 2024 Dec;
9(6):492-500.
PMID: 39735374
Purpose: Epidemiologic studies suggest that the transgender population has a higher burden of cardiovascular (CV) disease. We aimed to assess CV risk and investigate the relationship between estradiol (E2) or...
2.
Coelho L, Luz P, Pires D, Jalil E, Perazzo H, Torres T, et al.
Lancet Reg Health Am
. 2024 Jul;
36:100824.
PMID: 38993539
Background: Household transmission studies seek to understand the transmission dynamics of a pathogen by estimating the risk of infection from household contacts and community exposures. We estimated within/extra-household SARS-CoV-2 infection...
3.
Psaros C, Goodman G, Lee J, Rice W, Kelley C, Oyedele T, et al.
J Int AIDS Soc
. 2024 May;
27(5):e26252.
PMID: 38783534
Introduction: HPTN 083 demonstrated the superiority of long-acting cabotegravir (CAB-LA) versus daily oral emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) as pre-exposure prophylaxis (PrEP) among cisgender men and transgender women who have sex...
4.
Coelho L, Chazallon C, Laureillard D, Escada R, Ntakpe J, Timana I, et al.
Open Forum Infect Dis
. 2024 Mar;
11(3):ofae035.
PMID: 38486816
Background: After antiretroviral therapy (ART) initiation, people with HIV (PWH) treated for tuberculosis (TB) may develop TB-associated immune reconstitution inflammatory syndrome (TB-IRIS). Integrase inhibitors, by providing a faster HIV-RNA decline...
5.
Silva K, Ferreira R, Coelho L, Veloso V, Grinsztejn B, Torres T, et al.
J Int AIDS Soc
. 2024 Feb;
27(2):e26220.
PMID: 38379186
Introduction: Although strong scientific evidence of the efficacy and effectiveness of treatment-as-prevention (TasP) is available, full endorsement of the "Undetectable = Untransmittable" (U = U) and "zero-risk" messages could be...
6.
Motta E, Camacho L, Filippis A, Costa M, Pedro L, Cardoso S, et al.
Braz J Infect Dis
. 2024 Feb;
28(1):103719.
PMID: 38341187
Background: Safety data on the yellow fever vaccine 17DD in People Living with HIV (PLWH) are limited. This study explored the occurrence of post-vaccination 17DD viremia and the kinetics of...
7.
da Fonseca G, Cavalcante L, Brustolini O, Luz P, Pires D, Jalil E, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37685953
The innate immune system is the first line of defense against pathogens such as the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The type I-interferon (IFN) response activation during the initial...
8.
Motta E, Camacho L, Cunha M, de Filippis A, Lima S, Costa M, et al.
AIDS
. 2023 Aug;
37(15):2319-2329.
PMID: 37650759
Objective: To evaluate immunogenicity and reactogenicity of yellow fever (YF) vaccine in people with HIV (PWH) compared to HIV-uninfected controls. Design: In this longitudinal interventional trial (NCT03132311), PWH with CD4...
9.
Zachek C, Coelho L, Clark J, Domingues R, Luz P, Friedman R, et al.
Braz J Infect Dis
. 2023 May;
27(4):102779.
PMID: 37230150
Syndemic psychosocial and reproductive factors affecting women's retention in HIV care remain understudied. We analyzed correlates of non-retention in a cohort of women with HIV in Brazil from 2000‒2015. Participants...
10.
Torres T, Nascimento A, Coelho L, Konda K, Vega-Ramirez E, Elorreaga O, et al.
Ther Adv Infect Dis
. 2023 Feb;
10:20499361231153548.
PMID: 36814515
Background: Pre-exposure prophylaxis (PrEP) scale-up is urgent to reduce new HIV cases among gay, bisexual, and other men who have sex with men (MSM) in Latin America. Different PrEP modalities...